Pure Health Products by Can B Corp. obtains GMP certification from NSF

Independent certification allows the company to produce for major retailers around the world

HICKSVILLE, NY, December 30, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in the development, production and sale of cannabinoid products derived from hemp, is pleased to announce that its Pure Health The product subsidiary has obtained GMP NSF / ANSI 455-2 dietary supplement certification from NSF International for its manufacturing facility in Lacey, Washington.

Marco Alfonsi, CEO of Can B, said: “This independent certification from the World Public Health Organization demonstrates our commitment to the quality of personal care products and compliance with US GMP requirements. It verifies that our manufacturing plant has the appropriate methods, equipment, facilities and controls to produce food supplements. The importance of this award is that it now allows us to deal for any establishment across the planet.

Pure Health Products is a leader in the formulation and manufacture of CBD products derived from hemp. The Pure Health team have been pioneers and innovators contributing to the evolution of the hemp industry. In our state-of-the-art facilities, we can private label an existing product line for any business, and / or our formulators can tailor-make products designed to address a target market.

NSF / ANSI 455 GMP standards are designed to enhance safety, quality and confidence throughout the supply chain, combine regulatory requirements with retailer quality requirements and reduce the number of audits and costs financial resources associated with audits. Using the GMP guidelines helps companies develop and maintain appropriate controls in their manufacturing process so that products are processed, manufactured and labeled consistently and meet quality standards.

“The NSF / ANSI 455 GMP mark indicates that an NSF International auditor has audited a facility, verified documents and found the facility to comply with GMP regulations for production,” said David Trosin, general manager, Global Health Sciences Certification at NSF International. “We are very pleased to grant NSF / ANSI 455 GMP certification to this Pure Health Products manufacturing facility.

NSF International is a global public health organization that facilitates new language standards, and tests and certifies products for the water, food, health sciences, and consumer goods industries to minimize the effects harmful to health and protect the environment. Founded in 1944, NSF is committed to protecting human health and safety around the world. With operations in more than 175 countries, NSF International is a Pan American Health Organization / World Health Organization (WHO) collaborating center on food safety, water quality and the indoor environment.

For more information on NSF, please visit:

https://www.nsf.org/knowledge-library/nsf-ansi-455-2-dietary-supplements

About Can B Corp.

Can B Corp. (OTCQB: CANB) is a health and wellness company that provides the highest quality hemp-derived cannabinoid products, including under its own brands Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B uses multi-channel distribution to reach consumers including medical facilities, doctor’s offices, retailers, online and directly. Can B Corp. operates R&D and production facilities in Lacey, WA and Florida. To learn more about Can B Corp. and our full line of high quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the more than 1,000 outlets that sell Can B Corp products.

For more information on Can B Corp., please visit: CanBCorp.com

Twitter @CorpCanBC

Instagram @canbcorp

Facebook @ Can B Corp

Youtube

Forward-looking statements

The forward-looking statements and the risks and uncertainties discussed in this press release contain forward-looking statements. The words “anticipate”, “believe”, “estimate”, “may”, “intend”, “expect” and similar expressions identify such forward-looking statements. The expected and actual results, performances or achievements could differ materially from those envisaged, expressed or implied by the forward-looking statements contained in this document. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks and uncertainties associated with, among others, the impact of economic, competitive and other factors affecting our operations, markets, products and performance. . The matters discussed in this document should not be interpreted in any way or in any way regarding our future financial condition or the share price. Except as required by law, we do not undertake to update or revise any forward-looking statements publicly, whether as a result of the latest information, future events or otherwise, after the date on which the statements are made. made or to reflect the occurrence of unforeseen events.

Investors and media:

[email protected]
(917) 658-7878

Maria J. Book